Synthesis of (2S,4S)- and (2S,4R)-5-fluoroleucine and (2S,4S)-[5,5-2H2]-5-fluoroleucine

Syntheses of (2S,4S)- and (2S,4R)-5-fluoroleucine, and, and of (2S,4S)-[5,5-(2)H(2)]-5-fluoroleucine, have been completed. The methodology allows these compounds to be prepared in sufficient quantities for incorporation by solid-state protein synthesis into strategic sites in proteins for folding studies. X-ray structures of the epimers and have been obtained and show the presence of conformational isomerism. The torsion angles between the F-C bond and the main chain are compared with values found in a mutant of the protein ubiquitin in which (2S,4S)-5-fluoroleucine replaces leucine residues 50 and 67 in the native protein.     

Convenient synthesis of （2S,3R,4R,5S,6R）-2-（3-（4-ethylbenzyl）-4- chlorophenyl）-6-（hydroxymethyl）-tetrahydro- 2H-pyran-3,4,5-triol

A convenient approach for the preparation of （2S,3R,4R,5S,6R）-2-（3-（4-ethylbenzyl）-4-chlorophenyl）-6-（hydroxymethyl）- tetrahydro-2H-pyran-3,4,5-triol I is developed. The target compound via four steps is synthesized from 4-bromo-2-（bromomethyl）- 1-chlorobenzene and the isomers of undesired ortho-products were avoided during the preparation.     

Copper(II) complexes of 2-formyl-, 6-methyl-2-formyl- and 2-benzoylpyridine N(4)-(2-methylpyridinyl)-,N(4)-(2-ethylpyridinyl)-and N(4)-methyl(2-ethylpyridinyl)thiosemicarbazones

Summary The title complexes of general formula [Cu(HL)Cl₂] or [Cu(L)Cl] have been isolated and characterized by ¹H and ¹³C-n.m.r., i.r. and electronic spectra. The i.r., electronic and e.s.r. spectral data for the Cu^II complexes are compared with those of previously studied complexes. The antitumour and antiviral activities of the thiosemicarbazones and their complexes are discussed.     

Synthesis and Structural Determination of (2R,4S,SS)-( )-Threo-5-(2,2-dichloroacetamido)-4-(4-nitrophenyl)-2-aryl-1,3-dioxanes

Acetalscanbesynthesizedinanumberofways.Themainproblemintheacetalformationinacidicmediumistoshifttheequilibriumtotherightbyremovalofthewaterformedduringthereactionl.Wesynthesized(2R,4S,SS)-( )-threo-5-(2,2-dich(4-nitrophenyl)-2-aryl-1,3-dioxanesbyacet...     

Mesomorphic properties of 2-acyloxy5-(4-alkoxyphenylazo)tropones, 2-acyloxy-5-(4-alkylphenylazo)tropones,and 2-acyloxy-5-(4-alkoxycarbonylphenylazo)tropones

Three series of mesomorphic 2-acyloxy-5-phenylazotropones with alkoxy, alkyl, and alkoxycarbonyl groups at C-4 on the phenyl ring were prepared. It was known that the corresponding 5-phenylazotropolone derivatives and their methyl ethers were not mesomorphic. 2-Acetyl-5-(4-hexyloxyphenylazo)tropone, however, shows a monotropic smectic A phase. Even an acetyl group is therefore able to induce a mesophase. The effects of terminal substitution of the tropone ring by groups such as alkoxy, alkoxycarbonyl, and alkyl on the clearing points are discussed.     

A new route to (2S,4R)- and (2R,4S)-4-hydroxypipecolic acid

Both enantiomers of cis-4-hydroxypipecolic acid have been prepared by asymmetric synthesis using (S)- or (R)-glycidol as the chiral source, and involving a stereoselective hydrogenation of a six-membered cyclic imine. The latter is obtained by reduction and cyclization of a cyano β-hydroxy ketone.     

Mesomorphic properties of 2-acyloxy5-(4-alkoxyphenylazo)tropones, 2-acyloxy-5-(4-alkylphenylazo)tropones, and 2-acyloxy-5-(4-alkoxycarbonylphenylazo)tropones

Three series of mesomorphic 2-acyloxy-5-phenylazotropones with alkoxy, alkyl, and alkoxycarbonyl groups at C-4 on the phenyl ring were prepared. It was known that the corresponding 5-phenylazotropolone derivatives and their methyl ethers were not mesomorphic. 2-Acetyl-5-(4-hexyloxyphenylazo)tropone, however, shows a monotropic smectic A phase. Even an acetyl group is therefore able to induce a mesophase. The effects of terminal substitution of the tropone ring by groups such as alkoxy, alkoxycarbonyl, and alkyl on the clearing points are discussed.